Stocks · Health care · Services-Medical Laboratories

VERACYTE, INC.

VCYT Clue Score73
United States Fiscal year ends December CIK 0001384101 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Muna Bhanji
19 Oct 2026
Director
Sold on a plan
1,864
$43.70
$81.46K
John Leite
21 Sep 2026
Global Chief Commercial Off
Sold on a plan
4,015
$40.00
$160.60K
Jens Holstein
14 Sep 2026
Director
Sold on a plan
5,000
$40.95
$204.75K
Annie McGuire
4 Sep 2026
EVP, General Counsel
Sold on a plan
1,100
$43.67
$48.04K
Annie McGuire
4 Sep 2026
EVP, General Counsel
Sold on a plan
2,154
$42.79
$92.17K
Rebecca Chambers
4 Sep 2026
Chief Financial Officer
Sold on a plan
1,175
$43.71
$51.36K
Rebecca Chambers
4 Sep 2026
Chief Financial Officer
Sold on a plan
2,477
$42.81
$106.03K
Phillip G. Febbo
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
2,705
$43.66
$118.11K
Phillip G. Febbo
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
10,405
$42.89
$446.30K
Muna Bhanji
1 Sep 2026
Director
Sold on a plan
1,864
$42.97
$80.10K
Karin Eastham
18 Jun 2026
Director
Sold on a plan
529
$53.55
$28.33K
Karin Eastham
18 Jun 2026
Director
Sold on a plan
3,200
$52.78
$168.91K
John Leite
4 Jun 2026
Global Chief Commercial Off
Sold on a plan
13,975
$50.07
$699.73K
Rebecca Chambers
4 Jun 2026
Chief Financial Officer
Sold on a plan
1,961
$50.09
$98.23K
Rebecca Chambers
4 Jun 2026
Chief Financial Officer
Sold on a plan
1,600
$49.28
$78.85K
Annie McGuire
4 Jun 2026
EVP, General Counsel
Sold on a plan
1,776
$50.12
$89.01K
Annie McGuire
4 Jun 2026
EVP, General Counsel
Sold on a plan
1,400
$49.31
$69.03K
Robert S Epstein
20 May 2026
Director
Sold on a plan
10,000
$44.01
$440.13K
Annie McGuire
6 May 2026
SVP, General Counsel
Sold on a plan
5,102
$40.00
$204.08K
Annie McGuire
6 May 2026
SVP, General Counsel
Sold on a plan
5,102
$38.05
$194.13K
Annie McGuire
4 Mar 2026
SVP, General Counsel
Sold on a plan
1,664
$36.34
$60.47K
Annie McGuire
4 Mar 2026
SVP, General Counsel
Sold on a plan
4,994
$35.29
$176.26K
John Leite
4 Mar 2026
Chief Commercial Officer-CLIA
Sold on a plan
5,260
$35.19
$185.08K
Marc Stapley
4 Mar 2026
Chief Executive Officer
Sold on a plan
26,279
$36.28
$953.37K
Marc Stapley
4 Mar 2026
Chief Executive Officer
Sold on a plan
19,244
$35.56
$684.23K
Rebecca Chambers
4 Mar 2026
Chief Financial Officer
Sold on a plan
13,941
$36.33
$506.46K
Rebecca Chambers
4 Mar 2026
Chief Financial Officer
Sold on a plan
4,400
$35.55
$156.41K
Phillip G. Febbo
2 Mar 2026
Chief Scientific & Med Officer
Sold on a plan
13,425
$36.16
$485.43K
Annie McGuire
16 Dec 2025
SVP, General Counsel
Sold on a plan
100
$43.68
$4.37K
Annie McGuire
16 Dec 2025
SVP, General Counsel
Sold on a plan
10,639
$43.13
$458.84K
John Leite
4 Dec 2025
Chief Commercial Officer-CLIA
Sold on a plan
1,278
$47.51
$60.72K
Marc Stapley
4 Dec 2025
Chief Executive Officer
Sold on a plan
3,220
$47.35
$152.46K
Marc Stapley
4 Dec 2025
Chief Executive Officer
Sold on a plan
4,448
$46.90
$208.61K
Rebecca Chambers
4 Dec 2025
Chief Financial Officer
Sold on a plan
4,741
$47.25
$224.01K
Rebecca Chambers
4 Dec 2025
Chief Financial Officer
Sold on a plan
8,537
$46.61
$397.95K
Annie McGuire
4 Dec 2025
SVP, General Counsel
Sold on a plan
702
$47.51
$33.35K
Annie McGuire
4 Dec 2025
SVP, General Counsel
Sold on a plan
720
$47.10
$33.91K
Evan/ Fa Jones
25 Nov 2025
Director
Sold on a plan
1,106
$50.25
$55.58K
John Leite
25 Nov 2025
Chief Commercial Officer-CLIA
Sold on a plan
2,808
$50.00
$140.40K
Jens Holstein
20 Nov 2025
Director
Sold on a plan
1,460
$43.21
$63.09K
Jens Holstein
20 Nov 2025
Director
Sold on a plan
7,049
$42.48
$299.42K
Jens Holstein
20 Nov 2025
Director
Sold on a plan
1,491
$40.95
$61.06K

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 8
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,166,749
History held since 4 Nov 2013